Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript August 12, 2024
Esperion Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.328 EPS, expectations were $-0.15.
Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Esperion’s Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following the presentation there will be a question-and-answer session. Please be advised that today’s...
